Early T cell progenitor acute lymphoblastic leukemia
MONDO:0100291T acute lymphoblastic leukemia in which the blasts have unique immunophenotypic and genetic characteristics suggesting only limited early T-cell differentiation.
Also known as: ETP ALL, ETP-ALL, early T acute lymphoblastic leukaemia, early T acute lymphoblastic leukemia, early T-cell precursor acute lymphoblastic leukaemia, early T-cell precursor acute lymphoblastic leukemia, early T-cell precursor lymphoblastic leukaemia, early T-cell precursor lymphoblastic leukemia
1948 clinical trials for this condition and its sub-types, 4 tagged with Early T cell progenitor acute lymphoblastic leukemia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New hope for tough leukemia: capivasertib combo enters human trials
Disease control Recruiting nowThis study tests whether adding the experimental drug capivasertib to a standard treatment (venetoclax plus low-intensity chemotherapy) is safe and effective for adults with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma that has come back or not responded to prior …
Phase 1/2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for tough leukemia cases: drug combo trial opens for kids and young adults
Disease control Recruiting nowThis study is for children, teens, and young adults (ages 1 to 39) with acute leukemia that has come back or not gotten better with standard treatments. Researchers are testing whether combining two drugs—venetoclax and Vyxeos—is safe and tolerable. The goal is to find the best d…
Phase 1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Promising new combo tackles tough leukemia
Disease control Recruiting nowThis phase 2 trial is testing a five-drug combination for a rare, aggressive type of T-cell leukemia called ETP-ALL. The study aims to see if this mix can help more patients achieve remission after their first treatment. About 27 newly diagnosed adults will receive the drugs, and…
Phase 2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 26, 2026 15:21 UTC